Limb-Girdle Muscular Dystrophy Leaders Advance Collaborative Dialogue to Accelerate Drug Development to Address the Urgent Unmet Need in Limb-Girdle Muscular Dystrophy

/PRNewswire/ -- On February 8, 2024, The Speak Foundation, a patient-led 501(c)(3) organization for Limb-Girdle Muscular Dystrophy (LGMD), convened a...

Related Keywords

Rockville ,Maryland ,United States ,Texas ,Douglas Sproule ,Michelle Campbell ,Matthew Wicklund ,Jannie Kennedy ,Katherine Mathews ,Kathryn Bryant Knudson ,Nicholas Johnson ,Peter Marks ,Louise Rodino Klapac ,Nicole Verdun ,Lindsay Alfano ,Peter Kang ,Peter Stein ,James Signorovitch ,Jerryr Mendell ,Drug Administration ,Office Of New Drugs ,Everylife Foundation For Rare Diseases ,University Of Minnesota Medical School ,University Of Texas San Antonio ,Analysis Group ,Virginia Commonwealth University ,Drug Developers ,Speak Foundation ,University Of Iowa Health Care ,Ml Bio Solutions ,Community Leaders ,Limb Girdle Muscular Dystrophy ,Drug Evaluation ,Biologics Evaluation ,New Drugs ,Everylife Foundation ,Keynote Address ,Nationwide Children ,Senior Advisor ,Jennifer Levy ,Cure Calpain ,Sarepta Therapeutics ,Iowa Health Care ,Texas San Antonio ,Minnesota Medical School ,Caregiver Experiences ,Treatment Preferences ,Clinical Trial Design ,Girdle Muscular Dystrophy ,The Speak Foundation ,